GDF15 and cardiac hypertrophy: Interestingly, in mouse models of cardiac hypertrophy and myocardial infarction, GDF15 acts as a novel autocrine/endocrine factor that antagonizes the hypertrophic response and loss of ventricular performance, thereby preventing myocardial apoptosis and limiting infarct size [53].